Structure-activity relationship of amyloid fibrils

FEBS Letters

Volumn 583, Issue 16, 2009, Pages 2610-2617

  Maji, Samir K ^a   Wang, Lei ^b   Greenwald, Jason ^b   Riek, Roland ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b ETH ZURICH   (Switzerland)

Author keywords

Aggregation; Alzheimer's disease; Amyloid; Fibril; Nuclear magnetic resonance; Protein

Indexed keywords

AMYLOID; FUNGAL PROTEIN; PRION PROTEIN;

BETA SHEET; BIOLOGICAL ACTIVITY; HUMAN; HYPOTHESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE; SHORT SURVEY; SOLID STATE; THREE DIMENSIONAL IMAGING; X RAY CRYSTALLOGRAPHY;

AMYLOID; CRYSTALLOGRAPHY, X-RAY; HUMANS; NEURODEGENERATIVE DISEASES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, SECONDARY; STRUCTURE-ACTIVITY RELATIONSHIP;

HET-S PRION;

EID: 68649086842     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.07.003     Document Type: Short Survey

References (101)

1. Sipe J.D., and Cohen A.S. Review: history of the amyloid fibril. J. Struct. Biol. 130 (2000) 88-98
2. Westermark G.T., Johnson K.H., and Westermark P. Staining methods for identification of amyloid in tissue. Meth. Enzymol. 309 (1999) 3-25
3. Astbury W.T., Dickinson S., and Bailey K. CCLXXIX. The X-ray interpretation of denaturation and the structure of the seed globulins. Biochem. J. 29 (1935) 2351-2360
4. Sunde M., and Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein. Chem. 50 (1997) 123-159
5. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., and Blake C.C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273 (1997) 729-739
6. LeVine H. Quantification of β-sheet amyloid fibril structures with thioflavin T. Meth. Enzymol. 309 (1999) 274-284
7. Fradinger E.A., Maji S.K., Lazo N.D., and Teplow D.B. Studying amyloid beta-protein assembly. In: Xu W.X.a.H. (Ed). Amyloid Precursor Protein (2005), CRC Press, Boca Ration, London, New York, Washington, DC 83-110
8. Zhang R., Hu X., Khant H., Ludtke S.J., Chiu W., Schmid M.F., Frieden C., and Lee J.M. Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM. Proc. Natl. Acad. Sci. USA 106 (2009) 4653-4658
9. Luhrs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., Dobeli H., Schubert D., and Riek R. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. USA 102 (2005) 17342-17347
10. Vilar M., Chou H.T., Lührs T., Maji S.K., Riek-Loher D., Verel R., Manning G., Stahlberg H., and Riek R. The fold of alpha-synuclein fibrils. Proc. Natl. Acad. Sci. USA 105 (2008) 8637-8642
11. Margittai M., and Langen R. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q. Rev. Biophys. 41 (2008) 265-297
12. Kheterpal I., Cook K.D., and Wetzel R. Hydrogen/deuterium exchange mass spectrometry analysis of protein aggregates. Meth. Enzymol. 413 (2006) 140-166
13. Hoshino M., Katou H., Hagihara Y., Hasegawa K., Naiki H., and Goto Y. Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat. Struct. Biol. 9 (2002) 332-336
14. Ritter C., Maddelein M.L., Siemer A.B., Luhrs T., Ernst M., Meier B.H., Saupe S.J., and Riek R. Correlation of structural elements and infectivity of the HET-s prion. Nature 435 (2005) 844-848
15. Toyama B.H., Kelly M.J., Gross J.D., and Weissman J.S. The structural basis of yeast prion strain variants. Nature 449 (2007) 233-237
16. Lansbury Jr. P.T., Costa P.R., Griffiths J.M., Simon E.J., Auger M., Halverson K.J., Kocisko D.A., Hendsch Z.S., Ashburn T.T., Spencer R.G., et al. Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel β-sheet comprising a C-terminal peptide. Nat. Struct. Biol. 2 (1995) 990-998
17. Balbach J.J., Ishii Y., Antzutkin O.N., Leapman R.D., Rizzo N.W., Dyda F., Reed J., and Tycko R. Amyloid fibril formation by Ab(16-22), a seven-residue fragment of the Alzheimer's b-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39 (2000) 13748-13759
18. Benzinger T.L.S., Gregory D.M., Burkoth T.S., Millerauer H., Lynn D.G., Botto R.E., and Meredith S.C. Propagating structure of Alzheimers β-amyloid((10-35)) is parallel β-sheet with residues in exact register. Proc. Natl. Acad. Sci. USA 95 (1998) 13407-13412
19. Benzinger T.L.S., Gregory D.M., Burkoth T.S., Miller-Auer H., Lynn D.G., Botto R.E., and Meredith S.C. Two-dimensional structure of b-amyloid (10-35) fibrils. Biochemistry 39 (2000) 3491-3499
20. Petkova A.T., Ishii Y., Balbach J.J., Antzutkin O.N., Leapman R.D., Delaglio F., and Tycko R. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA 99 (2002) 16742-16747
21. Nelson R., Sawaya M.R., Balbirnie M., Madsen A.O., Riekel C., Grothe R., and Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 435 (2005) 773-778
22. Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., Apostol M.I., Thompson M.J., Balbirnie M., Wiltzius J.J., McFarlane H.T., Madsen A.O., Riekel C., and Eisenberg D. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447 (2007) 453-457
23. Paravastu A.K., Leapman R.D., Yau W.M., and Tycko R. Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc. Natl. Acad. Sci. USA 105 (2008) 18349-18354
24. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307 (2005) 262-265
25. Meinhardt J., Sachse C., Hortschansky P., Grigorieff N., and Fändrich M. Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J. Mol. Biol. 386 (2009) 869-877
26. Tanaka M., Chien P., Yonekura K., and Weissman J.S. Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins. Cell 121 (2005) 49-62
27. Wasmer C., Lange A., Van Melckebeke H., Siemer A.B., Riek R., and Meier B.H. Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science 319 (2008) 1523-1526
28. Steinbacher S., Baxa U., Miller S., Weintraub A., Seckler R., and Huber R. Crystal structure of phage P22 tailspike protein complexed with Salmonella sp. O-antigen receptors. Proc. Natl. Acad. Sci. USA 93 (1996) 10584-10588
29. Clantin B., Hodak H., Willery E., Locht C., Jacob-Dubuisson F., and Villeret V. The crystal structure of filamentous hemagglutinin secretion domain and its implications for the two-partner secretion pathway. Proc. Natl. Acad. Sci. USA 101 (2004) 6194-6199
30. Maddelein M.L., Dos Reis S., Duvezin-Caubet S., Coulary-Salin B., and Saupe S.J. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl. Acad. Sci. USA 99 (2002) 7402-7407
31. Sokolov Y., Kozak J.A., Kayed R., Chanturiya A., Glabe C., and Hall J.E. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J. Gen. Physiol. 128 (2006) 637-647
32. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
33. Krishnan R., and Lindquist S.L. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435 (2005) 765-772
34. Fowler D.M., Koulov A.V., Alory-Jost C., Marks M.S., Balch W.E., and Kelly J.W. Functional amyloid formation within mammalian tissue. PLoS Biol. 4 (2006) e6
35. Fowler D.M., Koulov A.V., Balch W.E., and Kelly J.W. Functional amyloid-from bacteria to humans. Trends Biochem. Sci. 32 (2007) 217-224
36. Barnhart M.M., and Chapman M.R. Curli biogenesis and function. Annu. Rev. Microbiol. 60 (2006) 131-147
37. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
38. Iconomidou V.A., Vriend G., and Hamodrakas S.J. Amyloids protect the silkmoth oocyte and embryo. FEBS Lett. 479 (2000) 141-145
39. Osherovich L.Z., and Weissman J.S. The utility of prions. Dev. Cell 2 (2002) 143-151
40. Maji, S.K., Perrin, M.H, Sawaya, M.R., Jessberger, S., Vadodaria, K., Rissman, R.A., Singru, P. S., Nilsson, K.P.R., Simon, R., Schubert, D., Eisenberg, D., Rivier, J., Sawchenko, P., Vale, W. and Riek R. (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science (on line).
41. Klein W.L., Stine Jr. W.B., and Teplow D.B. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol. Aging 25 (2004) 569-580
42. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
43. Lazo N.D., Maji S.K., Fradinger E.A., Bitan G., and Teplow D.B. The amyloid beta protein. In: Sipe J.D. (Ed). Amyloid Protein - The Beta Sheet Conformation and Disease (2005), Wiley-VCH Publishers, Weinheim, Germany 385-491
44. Chimon S., Shaibat M.A., Jones C.R., Calero D.C., Aizezi B., and Ishii Y. Evidence of fibril-like beta-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's beta-amyloid. Nat. Struct. Mol. Biol. 14 (2007) 1157-1164
45. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
46. Riek R. Cell biology: infectious Alzheimer's disease?. Nature 444 (2006) 429-431
47. Maji S.K., Schubert D., Rivier C., Lee S., Rivier J.E., and Riek R. Amyloid as a depot for the formulation of long-acting drugs. PloS Biol. 6 (2008) e17
48. Han H.Y., Weinreb P.H., and Lansbury P.T. The core Alzheimer's peptide Nac forms amyloid fibrils which seed and are seeded by β-Amyloid - is Nac a common trigger or target in neurodegenerative disease?. Chem. Biol. 2 (1995) 163-169
49. Giasson B.I., Forman M.S., Higuchi M., Golbe L.I., Graves C.L., Kotzbauer P.T., Trojanowski J.Q., and Lee V.M.Y. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300 (2003) 636-640
50. Anfinsen C.B. Principles that govern the folding of protein chains. Science 181 (1973) 223-230
51. Ventura S., and Villaverde A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 24 (2006) 179-185
52. Wang L., Maji S.K., Sawaya M.R., Eisenberg D., and Riek R. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol. 6 (2008) e195
53. Guijarro J.I., Sunde M., Jones J.A., Campbell I.D., and Dobson C.M. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. USA 95 (1998) 4224-4228
54. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., and Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. USA 96 (1999) 3590-3594
55. Dobson C.M. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (2001) 133-145
56. Nelson R., and Eisenberg D. Recent atomic models of amyloid fibril structure. Curr. Opin. Struct. Biol. 16 (2006) 260-265
57. Tjernberg L., Hosia W., Bark N., Thyberg J., and Johansson J. Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides. J. Biol. Chem. 277 (2002) 43243-43246
58. Margittai M., and Langen R. Side chain-dependent stacking modulates tau filament structure. J. Biol. Chem. 281 (2006) 37820-37827
59. Zanuy D., and Nussinov R. The sequence dependence of fiber organization. A comparative molecular dynamics study of the islet amyloid polypeptide segments 22-27 and 22-29. J. Mol. Biol. 329 (2003) 565-584
60. Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., and Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22 (2004) 1302-1306
61. Tartaglia G.G., Pawar A.P., Campioni S., Dobson C.M., Chiti F., and Vendruscolo M. Prediction of aggregation-prone regions in structured proteins. J. Mol. Biol. 380 (2008) 425-436
62. Polverino de Laureto P., Taddei N., Frare E., Capanni C., Costantini S., Zurdo J., Chiti F., Dobson C.M., and Fontana A. Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis. J. Mol. Biol. 334 (2003) 129-141
63. Marcon G., Plakoutsi G., Canale C., Relini A., Taddei N., Dobson C.M., Ramponi G., and Chiti F. Amyloid formation from HypF-N under conditions in which the protein is initially in its native state. J. Mol. Biol. 347 (2005) 323-335
64. Eisenberg D., Nelson R., Sawaya M.R., Balbirnie M., Sambashivan S., Ivanova M.I., Madsen A.O., and Riekel C. The structural biology of protein aggregation diseases: fundamental questions and some answers. Acc. Chem. Res. 39 (2006) 568-575
65. Bennett M.J., Sawaya M.R., and Eisenberg D. Deposition diseases and 3D domain swapping. Structure 14 (2006) 811-824
66. Valéry C., Paternostre M., Robert B., Gulik-Krzywicki T., Narayanan T., Dedieu J.C., Keller G., Torres M.L., Cherif-Cheikh R., Calvo P., and Artzner F. Biomimetic organization: octapeptide self-assembly into nanotubes of viral capsid-like dimension. Proc. Natl. Acad. Sci. USA 100 (2003) 10258-10262
67. Ryadnov M.G. Peptide alpha-helices for synthetic nanostructures. Biochem. Soc. Trans. 35 (2007) 487-491
68. Dvir H., Lundberg M.E., Maji S.K., Riek R., and Choe S. Mistic: cellular localization, solution behavior, polymerization, and fibril formation. Protein Sci. 18 (2009) 1564-1570
69. Wiltzius J.J., Sievers S.A., Sawaya M.R., Cascio D., Popov D., Riekel C., and Eisenberg D. Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin). Protein Sci. 17 (2008) 1467-1474
70. Antzutkin O.N., Leapman R.D., Balbach J.J., and Tycko R. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry 41 (2002) 15436-15450
71. Jaroniec C.P., MacPhee C.E., Astrof N.S., Dobson C.M., and Griffin R.G. Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril. Proc. Natl. Acad. Sci. USA 99 (2002) 16748-16753
72. Petkova A.T., Buntkowsky G., Dyda F., Leapman R.D., Yau W.M., and Tycko R. Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide. J. Mol. Biol. 335 (2004) 247-260
73. Kammerer R.A., Kostrewa D., Zurdo J., Detken A., Garcia-Echeverria C., Green J.D., Muller S.A., Meier B.H., Winkler F.K., Dobson C.M., and Steinmetz M.O. Exploring amyloid formation by a de novo design. Proc. Natl. Acad. Sci. USA 101 (2004) 4435-4440
74. Iwata K., Fujiwara T., Matsuki Y., Akutsu H., Takahashi S., Naiki H., and Goto Y. 3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR. Proc. Natl. Acad. Sci. USA 103 (2006) 18119-18124
75. Tycko R., Sciarretta K.L., Orgel J.P., and Meredith S.C. Evidence for novel-sheet structures in Iowa-mutant beta - amyloid fibrils. Biochemistry 48 (2009) 6072-6084
76. Paravastu A.K., Qahwash I., Leapman R.D., Meredith S.C., and Tycko R. Seeded growth of {beta}-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc. Natl. Acad. Sci. USA 106 (2009) 7443-7448
77. Heise H., Hoyer W., Becker S., Andronesi O.C., Riedel D., and Baldus M. Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. USA 102 (2005) 15871-15876
78. Baxa U., Wickner R.B., Steven A.C., Anderson D.E., Marekov L.N., Yau W.M., and Tycko R. Characterization of beta-sheet structure in Ure2p1-89 yeast prion fibrils by solid-state nuclear magnetic resonance. Biochemistry 46 (2007) 13149-13162
79. Chan J.C., Oyler N.A., Yau W.M., and Tycko R. Parallel beta-sheets and polar zippers in amyloid fibrils formed by residues 10-39 of the yeast prion protein Ure2p. Biochemistry 44 (2005) 10669-10680
80. Luca S., Yau W., Leapman R., and Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry 46 (2007) 13505-13522
81. Nielsen J.T., Bjerring M., Jeppesen M.D., Pedersen R.O., Pedersen J.M., Hein K.L., Vosegaard T., Skrydstrup T., Otzen D.E., and Nielsen N.C. Unique identification of supramolecular structures in amyloid fibrils by solid-state NMR spectroscopy. Angew. Chem., Int. Ed. Engl. 48 (2009) 2118-2121
82. Madine J., Jack E., Stockley P.G., Radford S.E., Serpell L.C., and Middleton D.A. Structural insights into the polymorphism of amyloid-like fibrils formed by region 20-29 of amylin revealed by solid-state NMR and X-ray fiber diffraction. J. Am. Chem. Soc. 130 (2008) 14990-15001
83. Shewmaker F., Wickner R.B., and Tycko R. Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc. Natl. Acad. Sci. USA 103 (2006) 19754-19759
84. Wickner R.B., Dyda F., and Tycko R. Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register beta-sheet structure. Proc. Natl. Acad. Sci. USA 105 (2008) 2403-2408
85. Helmus J.J., Surewicz K., Nadaud P.S., Surewicz W.K., and Jaroniec C.P. Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc. Natl. Acad. Sci. USA 105 (2008) 6284-6289
86. Laws D.D., Bitter H.M.L., Liu K., Ball H.L., Kaneko K., Wille H., Cohen F.E., Prusiner S.B., Pines A., and Wemmer D.E. Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration. Proc. Natl. Acad. Sci. USA 98 (2001) 11686-11690
87. Lim K.H., Nguyen T.N., Damo S.M., Mazur T., Ball H.L., Prusiner S.B., Pines A., and Wemmer D.E. Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89-143(P101L). Solid State Nucl. Magn. Reson. 29 (2006) 183-190
88. Kuwata K., Matumoto T., Cheng H., Nagayama K., James T.L., and Roder H. NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126. Proc. Natl. Acad. Sci. USA 100 (2003) 14790-14795
89. Ferguson N., Becker J., Tidow H., Tremmel S., Sharpe T.D., Krause G., Flinders J., Petrovich M., Berriman J., Oschkinat H., and Fersht A.R. General structural motifs of amyloid protofilaments. Proc. Natl. Acad. Sci. USA 103 (2006) 16248-16253
90. Olofsson A., Ippel J.H., Wijmenga S.S., Lundgren E., and Ohman A. Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J. Biol. Chem. 279 (2004) 5699-5707
91. Olofsson A., Sauer-Eriksson A.E., and Ohman A. The solvent protection of alzheimer amyloid-beta-(1-42) fibrils as determined by solution NMR spectroscopy. J. Biol. Chem. 281 (2006) 477-483
92. Olofsson A., Lindhagen-Persson M., Sauer-Eriksson A.E., and Ohman A. Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions. Biochem. J. 404 (2007) 63-70
93. Verel R., Tomka I.T., Bertozzi C., Cadalbert R., Kammerer R.A., Steinmetz M.O., and annd Meier B.H. Polymorphism in an amyloid-like fibril-forming model peptide. Angew. Chem., Int. Ed. Engl. 47 (2008) 5842-5845
94. Alexandrescu A.T. An NMR-based quenched hydrogen exchange investigation of model amyloid fibrils formed by cold shock protein A. Pac. Symp. Biocomput. (2001) 67-78
95. Ippel J.H., Olofsson A., Schleucher J., Lundgren E., and Wijmenga S.S. Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy. Proc. Natl. Acad. Sci. USA 99 (2002) 8648-8653
96. Madine J., Copland A., Serpell L.C., and Middleton D.A. Cross-beta spine architecture of fibrils formed by the amyloidogenic segment NFGSVQFV of medin from solid-state NMR and X-ray fiber diffraction measurements. Biochemistry 48 (2009) 3089-3099
97. Lee S.W., Mou Y., Lin S.Y., Chou F.C., Tseng W.H., Chen C.H., Lu C.Y., Yu S.S., and Chan J.C. Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein. J. Mol. Biol. 378 (2008) 1142-1154
98. Wilson L.M., Mok Y.F., Binger K.J., Griffin M.D., Mertens H.D., Lin F., Wade J.D., Gooley P.R., and Howlett G.J. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. J. Mol. Biol. 366 (2007) 1639-1651
99. Bu Z., Shi Y., Callaway D.J., and Tycko R. Molecular alignment within beta-sheets in Abeta(14-23) fibrils: solid-state NMR experiments and theoretical predictions. Biophys. J. 92 (2007) 594-602
100. Whittemore N.A., Mishra R., Kheterpal I., Williams A.D., Wetzel R., and Serpersu E.H. Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy. Biochemistry 44 (2005) 4434-4441
101. Naito A., Kamihara M., Inoue R., and Saitô H. Structural diversity of amyloid fibril formed in human calcitonin as revealed by site-directed 13C solid-state NMR spectroscopy. Magn. Reson. Chem. 42 (2004) 247-257